院内心脏骤停后的急性肾损伤
66%发生严重AKI(KDIGO 2-3期),心脏疾病亚组发生率更高(72% vs 56%)。低温与常温组严重AKI发生率无差异(63% vs 70%)。严重AKI与出院生存率降低(48% vs 65%)及12个月生存且神经行为良好结局降低(30% vs 53%)相关。
要点
- 院内心脏骤停患儿严重AKI(KDIGO 2-3期)发生率为66%,任何分期AKI为80%。
- 心脏疾病患儿严重AKI发生率更高(72% vs 56%,p=0.006)。
- 低温治疗未降低严重AKI发生率(63% vs 70%,p=0.23)。
- 严重AKI与出院生存率降低相关(48% vs 65%,p=0.006)。
- 严重AKI与12个月生存且神经行为良好结局降低相关(30% vs 53%,p<0.001)。
适用人群与场景
- THAPCA-IH试验纳入的院内心脏骤停患儿,随机后24小时内检测血清肌酐者。
- 分析按整个队列和心脏疾病亚组分层进行。
诊断标准与关键阈值
- 严重AKI定义为KDIGO肌酐标准2期或3期。
- 任何分期AKI依据KDIGO肌酐标准。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原有心脏或肾脏疾病、基线乳酸、血管活性药物支持及收缩压与严重AKI相关。
研究设计与关键结果
- 主要终点:严重AKI发生率66%(207例),任何分期AKI 80%(249例)。
- 心脏疾病亚组(204例,65%)严重AKI发生率72% vs 非心脏亚组56%(p=0.006)。
- 低温与常温组严重AKI发生率63% vs 70%(p=0.23),峰值肌酐、达峰时间及无死亡或严重AKI生存均无差异(p=0.14)。
- 严重AKI组出院生存率48% vs 无严重AKI组65%(p=0.006);12个月生存且神经行为良好结局30% vs 53%(p<0.001)。
证据类型、等级与局限
- 证据类型:随机对照试验的二次分析。
- 局限:二次分析,仅纳入随机后24小时内检测肌酐的患儿。
对床旁实践的改变
- 院内心脏骤停患儿应监测肌酐以识别严重AKI,尤其原有心脏或肾脏疾病及围骤停血流动力学不稳定者。
- 低温治疗不应以降低AKI发生率为目的使用。
- 发生严重AKI提示预后不良,需加强监护与家属沟通。
指南或共识出处
- THAPCA-IH试验(Therapeutic Hypothermia after Pediatric Cardiac Arrest In-Hospital)。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: Determine 1) frequency and risk factors for acute kidney injury (AKI) after in-hospital cardiac arrest (IHCA) in the Therapeutic Hypothermia after Pediatric Cardiac Arrest In-Hospital (THAPCA-IH) trial and associated outcomes; 2) impact of temperature management on post-IHCA AKI.
METHODS: Secondary analysis of THAPCA-IH; a randomized controlled multi-national trial at 37 children's hospitals.
ELIGIBILITY: Serum creatinine (Cr) within 24 h of randomization.
OUTCOMES: Prevalence of severe AKI defined by Stage 2 or 3 Kidney Disease Improving Global Outcomes Cr criteria. 12-month survival with favorable neurobehavioral outcome. Analyses stratified by entire cohort and cardiac subgroup. Risk factors and outcomes compared among cohorts with and without severe AKI.
RESULTS: Subject randomization: 159 to hypothermia, 154 to normothermia. Overall, 80% (249) developed AKI (any stage), and 66% (207) developed severe AKI. Cardiac patients (204, 65%) were more likely to develop severe AKI (72% vs 56%,p = 0.006). Preexisting cardiac or renal conditions, baseline lactate, vasoactive support, and systolic blood pressure were associated with severe AKI. Comparing hypothermia versus normothermia, there were no differences in severe AKI rate (63% vs 70%,p = 0.23), peak Cr, time to peak Cr, or freedom from mortality or severe AKI (p = 0.14). Severe AKI was associated with decreased hospital survival (48% vs 65%,p = 0.006) and decreased 12-month survival with favorable neurobehavioral outcome (30% vs 53%,p < 0.001).
CONCLUSION: Severe post-IHCA AKI occurred frequently especially in those with preexisting cardiac or renal conditions and peri-arrest hemodynamic instability. Severe AKI was associated with decreased survival with favorable neurobehavioral outcome. Hypothermia did not decrease incidence of severe AKI post-IHCA.
参考来源
- Mah KE, Alten JA, Cornell TT, et al. Acute kidney injury after in-hospital cardiac arrest. Resuscitation. 2021. PMID: 33450335. doi:10.1016/j.resuscitation.2020.12.023
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。